Alto Neuroscience, Inc. (ANRO)

Ticker: ANRO

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale

Past 90 days

Past 90 days

Past 90 days

Past 90 days

Company data

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2024-07-11	2024-07-10	B Purchase	Savitz Adam CHIEF MEDICAL OFFICER Officer	2,931 +7.9% 13.22 USD 38,748	2,931 +7.9%	13.22	USD 38,748
2024-07-11	2024-07-09	B Purchase	Savitz Adam CHIEF MEDICAL OFFICER Officer	1,388 +3.9% 13.15 USD 18,252	1,388 +3.9%	13.15	USD 18,252
2024-07-11	2024-07-09	B Purchase	Savitz Adam CHIEF MEDICAL OFFICER Officer	10,681 +43.0% 12.53 USD 133,833	10,681 +43.0%	12.53	USD 133,833
2024-04-01	2024-03-28	B Purchase	Smith Nicholas Conrad CHIEF FINANCIAL OFFICER Officer	4,550 +20.4% 16.56 USD 75,348	4,550 +20.4%	16.56	USD 75,348
2024-04-01	2024-03-28	B Purchase	Smith Nicholas Conrad CHIEF FINANCIAL OFFICER Officer	1,600 +7.7% 15.80 USD 25,280	1,600 +7.7%	15.80	USD 25,280
2024-02-08	2024-02-06	B Purchase	Alpha Wave Global, LP Large shareholder	600,000 +19.3% 16.00 USD 9,600,000	600,000 +19.3%	16.00	USD 9,600,000
2024-02-07	2024-02-06	B Purchase	Smith Nicholas Conrad CHIEF FINANCIAL OFFICER Officer	1,563 +inf% 16.00 USD 25,008	1,563 +inf%	16.00	USD 25,008
2024-02-07	2024-02-06	B Purchase	Savitz Adam CHIEF MEDICAL OFFICER Officer	17,000 +216.5% 16.00 USD 272,000	17,000 +216.5%	16.00	USD 272,000
2024-02-07	2024-02-06	B Purchase	Etkin Amit PRESIDENT AND CEO Executive Director	3,125 +0.3% 16.00 USD 50,000	3,125 +0.3%	16.00	USD 50,000